Galderma Launches Alastin in Japan, Soon to Singapore, South Korea
Galderma announced the launch of Alastin across the Japan and Asia Pacific (JPAC) region. The regenerative skincare brand recently launched in Taiwan, will soon launch in Japan, and has received approval to launch in Singapore and South Korea, with planned market introduction in September and November, respectively.
This expansion follows Alastin’s recent launches in China and Australia and underscores Galderma’s continued investment in JPAC, a region characterized by advanced skincare practices and rapid growth in injectable aesthetics. This is increasing demand for integrated skincare solutions that support skin readiness, recovery and long-term quality.
With more than 60 international dermatological publications and over 25 granted patents, Alastin is one of the most clinically studied skincare brands. In the United States it is the number one peri-procedural option and continues to be one of the fastest-growing global medical aesthetics skincare brands. It is powered by a proprietary peptide-based synergistic combination of ingredients and supported by real-world clinical experience demonstrating high levels of patient satisfaction, including improvements in radiance, recovery following procedures, and sustained hydration as well as overall skin resilience.
The Alastin Skincare portfolio uses deep regenerative science to push the boundaries of what skincare can do and address a broad spectrum of needs across the aesthetic journey. Nine products will be available in the JPAC region, including:
- Procedure support products, Skin Nectar and INhance – both with TriHex Technology® – developed for peri-procedural use to enhance visible outcomes and reduce recovery time
- Daily treatment products:
- Rejuvenate products, designed to support ongoing collagen and elastin renewal: Restorative Skin Complex with TriHex+™, Restorative Eye Complex with TriHex Technology®, and Restorative Neck Complex with TriHex Technology®
- Targeted serums formulated to address specific skin concerns: C-RADICAL Defense (an antioxidant serum that protects against environmental stressors), A-LUMINATE Brightening Serum™ (reduces the appearance of hyperpigmentation and discoloration for a more even skin tone), and HA IMMERSE Serum™ (enhances skin hydration)
- Daily care products to help moisturize, nourish and soothe skin: Ultra Nourishing Moisturizer with TriHex Technology®
“Alastin sets a new standard in regenerative skincare so we’re excited to bring it to patients and healthcare professionals in the JPAC region, where there is an ever-increasing demand for aesthetic procedures and peri-procedural care,” said Alan D. Widgerow, MBBCH, MMED, FCS, FACS, Galderma chief scientific officer and head of innovation, dermatological skincare, in a release. “As part of our commitment to delivering holistic regenerative skincare, the Alastin range is carefully curated to work synergistically with our Injectable Aesthetics portfolio, as well as daily skincare maintenance, enabling us to support patients with tailored solutions that address evolving needs.”
JPAC is a key growth engine for Galderma. By introducing Alastin, Galderma is expanding access to a holistic regenerative skincare portfolio designed to address some of today’s most significant aesthetic trends and needs, from an increased focus on skin quality and longevity, to growing concerns around menopause-related skin health, medication-driven weight loss, and aging.
